Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
HUTCHMED (China) Limited

HUTCHMED (China) Limited (HCM) Stock Overview

Explore HUTCHMED (China) Limited’s financial performance, market position, analyst ratings, and future outlook.

HCM●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$11.27
$0.43(3.92%)
U.S. Market is Open · 15:37

HUTCHMED (China) Limited (HCM)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio4.15
EPS (TTM)$2.67
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$13.16
3 Months$14.88
1 Year Target$14.22

HCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HUTCHMED (China) Limited (HCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.15 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.43%
5-Day Change
-0.44%
1-Month Change
13.31%
3-Month Change
-27.71%
6-Month Change
-27.53%
Year-to-Date (YTD) Change
-15.08%
1-Year Change
-36.19%
3-Year Change
-8.19%
5-Year Change
-71.73%
All-Time (Max) Change
-16.15%

Contact Information

https://www.hutch-med.com
852 2128 1188
Cheung Kong Center, Hong Kong, NaN, NaN

Company Facts

17,960 Employees
IPO DateMar 16, 2016
CountryHK
Actively Trading

Frequently Asked Questions